Concepedia

Hailun Li

HL

Statistics

Publications

32

Citations

2.2K

H-Index

25

Active since

2008

Affiliations

Dana-Farber Cancer Institute(Current)

BC Cancer Agency

Second People’s Hospital of Huai’an

Xuzhou Medical College

University of Wisconsin–Madison

Hailun Li is an author at Dana-Farber Cancer Institute specializing in oncology, medicine, and lymphoma treatment response.

ORCID

Publications per year

2008–2024

32

Publications

32

Heterogeneity for Stem Cell–Related Markers According to Tumor Subtype and Histologic Stage in Breast Cancer

So Yeon Park, Hee Eun Lee, Hailun Li et al. · Clinical Cancer Research · 2010 · 398 citations · Full text

, , +17

Dendrobium officinale polysaccharides alleviate colon tumorigenesis via restoring intestinal barrier function and enhancing anti-tumor immune response

Jian Liang, Hailun Li, Jianqiang Chen et al. · Pharmacological Research · 2019 · 148 citations

, , +17

Phase 2 trial of sorafenib in patients with advanced urothelial cancer

Robert Dreicer, Hailun Li, Mark N. Stein et al. · Cancer · 2009 · 142 citations · Full text

, , +9

Plasma Epstein-Barr virus DNA predicts outcome in advanced Hodgkin lymphoma: correlative analysis from a large North American cooperative group trial

Jennifer A. Kanakry, Hailun Li, Lan L. Gellert et al. · Blood · 2013 · 140 citations · Full text

, , +10

PIK3CA Mutations in <i>In situ</i> and Invasive Breast Carcinomas

Alexander Miron, Mária Váradi, Daniel R. Carrasco et al. · Cancer Research · 2010 · 131 citations · Full text

, , +17

1–5 of 32